These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1375487)

  • 1. Treatment of metastatic testicular tumours with bleomycin, etoposide, cisplatin and vincristine.
    Price BA; Peters NH
    Eur J Cancer; 1992; 28(2-3):615. PubMed ID: 1375487
    [No Abstract]   [Full Text] [Related]  

  • 2. The treatment of metastatic germ-cell testicular tumours with bleomycin, etoposide and cis-platin (BEP).
    Peckham MJ; Barrett A; Liew KH; Horwich A; Robinson B; Dobbs HJ; McElwain TJ; Hendry WF
    Br J Cancer; 1983 May; 47(5):613-9. PubMed ID: 6189504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Etoposide and cisplatin with or without bleomycin as first-line chemotherapy for patients with small-volume metastases of testicular nonseminoma.
    Peckham MJ; Horwich A; Blackmore C; Hendry WF
    Cancer Treat Rep; 1985 May; 69(5):483-8. PubMed ID: 2408750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reassessment of 4-Cycle Etoposide and Cisplatin as the Standard of Care for Good-Risk Metastatic Germ Cell Tumors.
    Fein DE; Paulus JK; Mathew P
    JAMA Oncol; 2018 Dec; 4(12):1661-1662. PubMed ID: 30325997
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies of the Australasian Germ Cell Trial Group: the management of advanced testis cancer.
    Raghavan D; Levi J; Thomson D; Harvey V
    Prog Clin Biol Res; 1990; 350():319-29. PubMed ID: 1696742
    [No Abstract]   [Full Text] [Related]  

  • 6. Bleomycin, vincristine, cisplatin/bleomycin, etoposide, cisplatin chemotherapy: an alternating, dose intense regimen producing promising results in untreated patients with intermediate or poor prognosis malignant germ-cell tumours.
    Anthoney DA; McKean MJ; Roberts JT; Hutcheon AW; Graham J; Jones W; Paul J; Kaye SB
    Br J Cancer; 2004 Feb; 90(3):601-6. PubMed ID: 14760371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Testicular malignant tumours. Efficacy of germ cell and sex cord tumours treatment protocol in Poland].
    Popadiuk S; Korzon M; Chybicka A; Szmyd K; Dzierzega M; Trelińska J; Kowalczyk JR; Wiśniewska-Slusarz H; Woźniak W; Bilska K; Wachowiak J; Konatkowska B; Wysocki M; Krawczuk-Rybak M; Czauderna P; Szumera M; Sznurkowska K; Renke J
    Med Wieku Rozwoj; 2006; 10(3 Pt 1):811-7. PubMed ID: 17317912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stage I testicular cancer management and necessity for surgical expertise.
    Sheinfeld J; Motzer RJ
    J Clin Oncol; 2008 Jun; 26(18):2934-6. PubMed ID: 18458042
    [No Abstract]   [Full Text] [Related]  

  • 9. [Chemotherapy of disseminated germ cell tumors of the testis].
    Tiuliandin SA
    Sov Med; 1987; (11):78-81. PubMed ID: 2451298
    [No Abstract]   [Full Text] [Related]  

  • 10. A randomized trial of cisplatin, vinblastine, and bleomycin versus vinblastine, cisplatin, and etoposide in the treatment of advanced germ cell tumors of the testis: a Southwest Oncology Group study.
    Wozniak AJ; Samson MK; Shah NT; Crawford ED; Ford CD; Altman SJ; Stephens RL; Natale RB; Bouroncle BA; Blumenstein BA
    J Clin Oncol; 1991 Jan; 9(1):70-6. PubMed ID: 1702148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of bleomycin on retroperitoneal histology at post-chemotherapy retroperitoneal lymph node dissection of good risk germ cell tumors.
    Cary KC; Pedrosa JA; Kaimakliotis HZ; Masterson TA; Einhorn LH; Foster RS
    J Urol; 2015 Feb; 193(2):507-12. PubMed ID: 25254937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-seminomatous germ cell tumours of the testis: game and set but not match.
    Thomson DB; Walpole ET; Grimes D
    Aust N Z J Med; 1991 Dec; 21(6):835-6. PubMed ID: 1726357
    [No Abstract]   [Full Text] [Related]  

  • 13. Failure of high-dose cyclophosphamide and etoposide combined with double-dose cisplatin and bone marrow support in patients with high-volume metastatic nonseminomatous germ-cell tumours: mature results of a randomised trial.
    Droz JP; Kramar A; Biron P; Pico JL; Kerbrat P; Pény J; Curé H; Chevreau C; Théodore C; Bouzy J; Culine S;
    Eur Urol; 2007 Mar; 51(3):739-46; discussion 747-8. PubMed ID: 17084512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternatives to standard BEP x 3 in good-prognosis germ cell tumors--you bet your life.
    Nichols C; Kollmannsberger C
    J Natl Cancer Inst; 2010 Aug; 102(16):1214-5. PubMed ID: 20631340
    [No Abstract]   [Full Text] [Related]  

  • 15. [Carboplatin-etoposide-bleomycine chemotherapy protocol in the treatment of patients with metastatic non-seminomatous germ-cell testicular tumours with good prognosis].
    Jeremić B; Djurić Lj; Djordjević S; Cirović V; Milojević Lj; Stanisavljević B; Matović M; Mijatović Lj
    Srp Arh Celok Lek; 1994; 122(9-10):257-9. PubMed ID: 17977429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current chemotherapy strategy in patients with germ cell tumors.
    Einhorn LH
    Eur Urol; 1993; 23 Suppl 2():47-8. PubMed ID: 7685703
    [No Abstract]   [Full Text] [Related]  

  • 17. Bleomycin in testicular cancer: will pharmacogenomics improve treatment regimens?
    Bokemeyer C
    J Clin Oncol; 2008 Apr; 26(11):1783-5. PubMed ID: 18398143
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of favorable-prognosis nonseminomatous testicular germ cell tumors with etoposide, cisplatin, and reduced dose of bleomycin.
    Brada M; Horwich A; Peckham MJ
    Cancer Treat Rep; 1987 Jun; 71(6):655-6. PubMed ID: 2438041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bilateral and synchronous testicular teratoma: a case report and literature review].
    Matabuena-Tamez P; Canepa-Fernández P; Valencia-García LC; Gutiérrez-Samperio C; Gallegos-Corona MA
    Cir Cir; 2015; 83(6):527-31. PubMed ID: 26164135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy for non-seminomatous germ-cell tumours.
    Wilkinson PM
    J R Soc Med; 1985; 78 Suppl 6(Suppl 6):43-7. PubMed ID: 2582119
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.